A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results